Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00446888 · ClinicalTrials.gov registry record · NA

Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer Patients

A NA study, sponsored by University of Arkansas.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT00446888 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00446888, a NA study, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

The purpose of the study is to compare two different nutritional supplements with respect to their effect on building muscle, and to determine the factors that control the rate at which muscle tissue can be produced in subjects with cancer. After three days of receiving all meals from the Reynolds Institute on Aging in order to stabilize their diet, subjects will then return to the Institute to perform a single day study, where they will be given one of two supplements to drink. Blood will be taken from a catheter placed in one of their arms and three muscle biopsy samples will be taken from a leg. Subjects will have x-ray evidence of cancer and be 40 years of age or older in order to participate. It is the hypothesis that a nutritional supplement with a high amount of protein and containing leucine will target the metabolism problems in cancer patients.

Interventions

  • BEHAVIORAL Standardized Meals for Diet Stabilization
  • DIETARY_SUPPLEMENT Forticare
  • DIETARY_SUPPLEMENT Product 4808

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2007-01
Est. Completion 2009-03
Phase NA

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT00446888

The ClinicalTrials.gov registry entry for NCT00446888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Standardized Meals for Diet Stabilization is the first listed.

NCT00446888 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00446888 about?

NCT00446888 is a clinical study titled "Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer Patients". The purpose of the study is to compare two different nutritional supplements with respect to their effect on building muscle, and to determine the factors that control the rate at which muscle tissue can be produced in subjects with cancer. After three days of receiving all meals from the Reynolds I...

What is the current status of trial NCT00446888?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2007-01. Estimated completion is 2009-03.

What interventions are being tested in trial NCT00446888?

The interventions under investigation include: Standardized Meals for Diet Stabilization (BEHAVIORAL), Forticare (DIETARY_SUPPLEMENT), Product 4808 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00446888?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.